The next generation biopharmaceuticals

Older press releases

Affibodys latest Press releases


Interview with Affibody’s CEO (in Swedish)

[read more]

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Upcoming reports Financial calendar

  • Interim Report Q1 (May 17, 2019)